Afternoon trading July 3, page-615

  1. 11,123 Posts.
    lightbulb Created with Sketch. 503
    LCT especially love the last part ay

    "All companies confirmed that our target, blockade of
    CGRP receptors, is valid."
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.